Item 2.01. Completion of Acquisition or Disposition of Assets.
On May 10, 2018, MACOM Japan Limited, a company established under the laws of Japan (MACOM Japan), completed the previously reported sale and transfer to CIG Shanghai Co., Ltd., a company established under the laws of PRC (the Buyer), of certain capital equipment, inventory and other assets associated with MACOM Japans long-range optical subassembly product line (the LR4 Business) and grant of a non-exclusive license to the Buyer with respect to related intellectual property, pursuant to the Asset Purchase and Intellectual Property License Agreement (the Agreement), dated April 30, 2018, by and among the Buyer, MACOM Japan and MACOM Technology Solutions Holdings, Inc., a Delaware corporation (the Company) (solely with respect to Sections 2.5 and 12.16 thereof), as amended by an Amendment to Asset Purchase and Intellectual Property License Agreement, dated May 10, 2018, by and among the Buyer and MACOM Japan (the Amendment and, together with the Agreement, the APA).
The APA provides that the Buyer will pay $5.0 million to MACOM Japan within 30 days following the closing of the transactions contemplated by the APA, provide the Company with the opportunity to supply components and will pay MACOM Japan an additional estimated $5.0 million and $12.0 million for certain capital equipment and inventory, respectively, within 60 days following the closing of the transactions contemplated by the APA, subject to receipt of required government approvals.
The foregoing descriptions of the APA and the transactions contemplated thereby do not purport to be complete and are subject to and qualified in their entirety by reference to the full text of the Agreement and the Amendment, copies of which are filed as Exhibits 2.1 and 2.2, respectively, to this Current Report on Form 8-K and incorporated herein by reference.
The representations, warranties and covenants contained in the Agreement and the Amendment were made only for purposes of each such agreement and as of specific dates, are solely for the benefit of the parties to each such agreement, are not intended as statements of fact to be relied upon by shareholders or other security holders of MACOM, may be subject to limitations agreed upon by the parties, including being qualified by confidential disclosures made for the purposes of allocating contractual risk between the parties to each such agreement, and may be subject to standards of materiality applicable to the parties that differ from those applicable to investors.
